BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14999811)

  • 1. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology.
    Ess KC; Uhlmann EJ; Li W; Li H; Declue JE; Crino PB; Gutmann DH
    Glia; 2004 Apr; 46(1):28-40. PubMed ID: 14999811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
    Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
    Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model.
    Wong M; Ess KC; Uhlmann EJ; Jansen LA; Li W; Crino PB; Mennerick S; Yamada KA; Gutmann DH
    Ann Neurol; 2003 Aug; 54(2):251-6. PubMed ID: 12891680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex.
    Ess KC; Kamp CA; Tu BP; Gutmann DH
    Neurology; 2005 Apr; 64(8):1446-9. PubMed ID: 15851742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes.
    Jansen LA; Uhlmann EJ; Crino PB; Gutmann DH; Wong M
    Epilepsia; 2005 Dec; 46(12):1871-80. PubMed ID: 16393152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.
    Uhlmann EJ; Wong M; Baldwin RL; Bajenaru ML; Onda H; Kwiatkowski DJ; Yamada K; Gutmann DH
    Ann Neurol; 2002 Sep; 52(3):285-96. PubMed ID: 12205640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
    Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
    Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberous sclerosis: a primary pathology of astrocytes?
    Sosunov AA; Wu X; Weiner HL; Mikell CB; Goodman RR; Crino PD; McKhann GM
    Epilepsia; 2008; 49 Suppl 2():53-62. PubMed ID: 18226172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
    Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
    Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1.
    Wang Y; Greenwood JS; Calcagnotto ME; Kirsch HE; Barbaro NM; Baraban SC
    Ann Neurol; 2007 Feb; 61(2):139-52. PubMed ID: 17279540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous sclerosis and epilepsy: role of astrocytes.
    Wong M; Crino PB
    Glia; 2012 Aug; 60(8):1244-50. PubMed ID: 22438024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation.
    Uhlmann EJ; Li W; Scheidenhelm DK; Gau CL; Tamanoi F; Gutmann DH
    Glia; 2004 Aug; 47(2):180-8. PubMed ID: 15185396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex.
    Zhang B; Zou J; Han L; Rensing N; Wong M
    Epilepsia; 2016 Aug; 57(8):1317-25. PubMed ID: 27263494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
    Su W; Xing R; Guha A; Gutmann DH; Sherman LS
    Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezrin and moesin expression within the developing human cerebrum and tuberous sclerosis-associated cortical tubers.
    Johnson MW; Miyata H; Vinters HV
    Acta Neuropathol; 2002 Aug; 104(2):188-96. PubMed ID: 12111362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
    Tavazoie SF; Alvarez VA; Ridenour DA; Kwiatkowski DJ; Sabatini BL
    Nat Neurosci; 2005 Dec; 8(12):1727-34. PubMed ID: 16286931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent meningitis associated with frontal sinus tuber encephalocele in a patient with tuberous sclerosis.
    Elbabaa SK; Riggs AD; Saad AG
    J Neurosurg Pediatr; 2011 Jul; 8(1):103-6. PubMed ID: 21721896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
    Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
    Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.
    Carson RP; Van Nielen DL; Winzenburger PA; Ess KC
    Neurobiol Dis; 2012 Jan; 45(1):369-80. PubMed ID: 21907282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex and epilepsy: recent developments and future challenges.
    Holmes GL; Stafstrom CE;
    Epilepsia; 2007 Apr; 48(4):617-30. PubMed ID: 17386056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.